Skip to main content
. 2024 Dec 19;12:159. doi: 10.1186/s40364-024-00705-7

Fig. 3.

Fig. 3

LILRB blockade in the tumor microenvironment. LILRB blockade prevents immunosuppressive signaling and improves T-cell cytolysis and monocyte phagocytosis in the TME. Created in BioRender. Dubuque, R. (2025) https://BioRender.com/q51d918